(clean up) |
No edit summary |
||
| Line 1: | Line 1: | ||
{{articletype|main}} |
{{articletype|main}} |
||
| − | '''''T-JCCC 203''''' was an experimental virus developed by the [[Umbrella Corporation]]. A strain of the [[t-Virus]], T-JCCC 203 was an "[[Wikipedia: |
+ | '''''T-JCCC 203''''' was an experimental virus developed by the [[Umbrella Corporation]]. A strain of the [[t-Virus]], T-JCCC 203 was an "[[Wikipedia:Oncolytic virus|oncolytic virus]]", a virus that specifically targets cancerous cells. |
==Research== |
==Research== |
||
| Line 11: | Line 11: | ||
<references/> |
<references/> |
||
| ⚫ | |||
[[Category:Viral agents]] |
[[Category:Viral agents]] |
||
[[Category:Umbrella products]] |
[[Category:Umbrella products]] |
||
| ⚫ | |||
Revision as of 12:14, 15 November 2014
()
T-JCCC 203 was an experimental virus developed by the Umbrella Corporation. A strain of the t-Virus, T-JCCC 203 was an "oncolytic virus", a virus that specifically targets cancerous cells.
Research
The strain was developed some time before March 1993, where it entered illegal clinical trials. Operating under the guise of a front, they provided the treatment to a hospital operating in the Arklay Mountains.[1]
The first test subject was a 63-year old man named Doug Frost, administered on March 14th. His cancer cells died through apoptosis, and he developed a voracious appetite. A sudden change in his condition led to his death just over three days after administration. The second test subject, the 34-year old Dorothy Lester, received an administration on March 20th. She was found to have regained normal blood pressure and pulse; self-respiration and conciousness after only a day. On the 23rd, she was experiencing unusual EEG readings alongside her voracious appetite, but the readings calmed back down.[1]
Sources
- ↑ 1.0 1.1 Resident Evil Outbreak File 2 (2004), file: "Clinical report"